Thomas Rosamond, MD, Wendell Yap, MD, and Joe Donald, MD
When chest pain patients arrive in the Emergency Department, diagnostic accuracy can mean the difference between life and death. This groundbreaking analysis from the University of Kansas Medical Center demonstrates why 13N-Ammonia PET/CT with Regadenoson stress testing represents a paradigm shift in emergency cardiac care.
The “Best in Class” Advantage:
- Lowest radiation exposure – Just 2mSv or less vs. higher doses with other tracers
- Superior diagnostic accuracy – Nearly 100% first-pass extraction vs. 50-60% for alternatives
- Exceptional image quality – Highest spatial resolution of available PET/SPECT tracers
- Quantitative blood flow analysis – The “elite” tool for coronary artery detection
- Reliable supply chain – On-site production eliminates third-party dependencies
Real-World Results: In their first 100 cases, the Kansas team achieved zero false negatives while reducing patient length of stay by 4-6 hours. Complete studies were finished and interpreted before noon, with total scan time of just 30 minutes.
This comprehensive white paper provides the scientific rationale, practical implementation strategies, and clinical outcomes that demonstrate why leading cardiologists are calling 13N-Ammonia the optimal solution for emergency cardiac evaluation.
